What Is Lytenava, and How Does It Work? Lytenava (bevacizumab) is now FDA approved to treat adults with neovascular age-related macular degeneration, which is also called wet AMD. Wet AMD is an eye ...
The market for treatments of macular degeneration, cited as the leading cause of blindness in the elderly, is growing rapidly. Macular degeneration is a condition where abnormal blood vessels grow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results